Form 4: Agilon Health Executive Acquires 45,000 Shares in Open Market Transaction
SEC Form 4 Filing
An executive at Agilon Health, John William Wulf, purchased 45,000 shares of common stock in multiple transactions at a weighted average price of $2.181 per share.
Summary
- John William Wulf, an executive at Agilon Health, acquired 45,000 shares of the company's common stock.
- The shares were purchased in multiple transactions on December 5, 2024.
- The weighted average price paid was $2.181 per share.
- The individual transaction prices ranged from $2.165 to $2.19 per share.
- The purchase also included restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as an executive purchasing shares can be seen as a positive sign, but it's a routine transaction.
Positives
- The purchase of shares by an executive may indicate confidence in the company's future prospects.
Industry Context
Executive stock purchases are a common occurrence and are often seen as a sign of confidence in the company's future performance.
Comparison to Industry Standards
- Executive stock purchases are a common practice across the industry, and this transaction is not unusual in terms of size or price range.
- It is common for executives to receive and purchase shares as part of their compensation packages.
Stakeholder Impact
- The stock purchase may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2024-12-05 | Date of the stock purchase transaction. |
| 2024-12-11 | Date of the filing. |
Keywords
Agilon Health, stock purchase, executive, insider trading, common stock, restricted stock units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.